factual

Pharma Externalizing R&D to Biotechs and CROs

Since the 2000s big pharma has externalized most research to venture-funded biotechs and clinical trials to contract research organizations, leaving big pharma as commercialization machines whose remaining labs mainly validate external opportunities, and this could extend to commercial analysis and eventually to IP-holding shells.

factualpending

Speaker

Alex

Evidence Quote

“So the big pharma companies are really just like commercialization machines all the time.”

Source

Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the Best
Created: 11/14/2026, 6:42:06 AM

Your notes

Loading notes...